KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic ResistanceKunihiko Hinohara, Kornélia Polyák, Anton Simeonov et al.|Cancer Cell|2018Cited by 255
Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibitionAnne Fassl, Piotr Siciński, Christopher T. Brain et al.|Science Advances|2020Cited by 105
JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell StatesLaura E. Stevens, Kornélia Polyák, Guillermo Peluffo et al.|Cancer Research|2022Cited by 101
Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory CancersPer Hydbring, Piotr Siciński, Yinan Wang et al.|Cancer Cell|2017Cited by 98
Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancerJennifer Y. Ge, Kornélia Polyák, Shaokun Shu et al.|Nature Communications|2020Cited by 97